195 related articles for article (PubMed ID: 35078861)
21. A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme.
Verma H; Cholia RP; Kaur S; Dhiman M; Mantha AK
Metab Brain Dis; 2021 Jun; 36(5):751-765. PubMed ID: 33651273
[TBL] [Abstract][Full Text] [Related]
22. Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis.
Xie J; Dai C; Hu X
J Biol Chem; 2016 Apr; 291(17):8987-99. PubMed ID: 26917721
[TBL] [Abstract][Full Text] [Related]
23. The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.
Bonuccelli G; Whitaker-Menezes D; Castello-Cros R; Pavlides S; Pestell RG; Fatatis A; Witkiewicz AK; Vander Heiden MG; Migneco G; Chiavarina B; Frank PG; Capozza F; Flomenberg N; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Cell Cycle; 2010 May; 9(10):1960-71. PubMed ID: 20495363
[TBL] [Abstract][Full Text] [Related]
24. Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer.
Mossa F; Robesti D; Sumankalai R; Corey E; Titus M; Kang Y; Zhang J; Briganti A; Montorsi F; Vellano CP; Marszalek JR; Frigo DE; Logothetis CJ; Gujral TS; Dondossola E
Mol Cancer Res; 2023 Jan; 21(1):51-61. PubMed ID: 36112348
[TBL] [Abstract][Full Text] [Related]
25. HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells.
Huang L; Yu Z; Zhang T; Zhao X; Huang G
PLoS One; 2014; 9(3):e92949. PubMed ID: 24658033
[TBL] [Abstract][Full Text] [Related]
26. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.
Sun Q; Chen X; Ma J; Peng H; Wang F; Zha X; Wang Y; Jing Y; Yang H; Chen R; Chang L; Zhang Y; Goto J; Onda H; Chen T; Wang MR; Lu Y; You H; Kwiatkowski D; Zhang H
Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4129-34. PubMed ID: 21325052
[TBL] [Abstract][Full Text] [Related]
27. GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism.
Zhou Q; Yin Y; Yu M; Gao D; Sun J; Yang Z; Weng J; Chen W; Atyah M; Shen Y; Ye Q; Li CW; Hung MC; Dong Q; Zhou C; Ren N
Redox Biol; 2022 Oct; 56():102458. PubMed ID: 36116159
[TBL] [Abstract][Full Text] [Related]
28. Pyruvate kinase, a metabolic sensor powering glycolysis, drives the metabolic control of DNA replication.
Horemans S; Pitoulias M; Holland A; Pateau E; Lechaplais C; Ekaterina D; Perret A; Soultanas P; Janniere L
BMC Biol; 2022 Apr; 20(1):87. PubMed ID: 35418203
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine kinase inhibitor imatinib modulates the viability and apoptosis of castrate-resistant prostate cancer cells dependently on the glycolytic environment.
Cardoso HJ; Vaz CV; Carvalho TMA; Figueira MI; Socorro S
Life Sci; 2019 Feb; 218():274-283. PubMed ID: 30605651
[TBL] [Abstract][Full Text] [Related]
30. EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer.
Lin SR; Wen YC; Yeh HL; Jiang KC; Chen WH; Mokgautsi N; Huang J; Chen WY; Liu YN
Oncogene; 2020 Oct; 39(44):6757-6775. PubMed ID: 32963351
[TBL] [Abstract][Full Text] [Related]
31. Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer.
Flores-Morales A; Bergmann TB; Lavallee C; Batth TS; Lin D; Lerdrup M; Friis S; Bartels A; Kristensen G; Krzyzanowska A; Xue H; Fazli L; Hansen KH; Røder MA; Brasso K; Moreira JM; Bjartell A; Wang Y; Olsen JV; Collins CC; Iglesias-Gato D
Clin Cancer Res; 2019 Jan; 25(2):595-608. PubMed ID: 30274982
[TBL] [Abstract][Full Text] [Related]
32. DNA-PKcs: A Targetable Protumorigenic Protein Kinase.
Dylgjeri E; Knudsen KE
Cancer Res; 2022 Feb; 82(4):523-533. PubMed ID: 34893509
[TBL] [Abstract][Full Text] [Related]
33. Cancer metabolism control by natural products: Pyruvate kinase M2 targeting therapeutics.
El-Far AH; Al Jaouni SK; Li X; Fu J
Phytother Res; 2022 Aug; 36(8):3181-3201. PubMed ID: 35794729
[TBL] [Abstract][Full Text] [Related]
34. Scaling with body mass and age in glycolytic enzymes of domestic dogs.
Wynkoop MR; Lalwani S; Cipolli W; Jimenez AG
Vet Res Commun; 2023 Jan; 47(1):39-50. PubMed ID: 35441335
[TBL] [Abstract][Full Text] [Related]
35. Effects of the human papilloma virus HPV-16 E7 oncoprotein on glycolysis and glutaminolysis: role of pyruvate kinase type M2 and the glycolytic-enzyme complex.
Mazurek S; Zwerschke W; Jansen-Dürr P; Eigenbrodt E
Biochem J; 2001 May; 356(Pt 1):247-56. PubMed ID: 11336658
[TBL] [Abstract][Full Text] [Related]
36. Regulation of DNA-dependent protein kinase by protein kinase CK2 in human glioblastoma cells.
Olsen BB; Issinger OG; Guerra B
Oncogene; 2010 Nov; 29(45):6016-26. PubMed ID: 20711232
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cells.
Azad A; Jackson S; Cullinane C; Natoli A; Neilsen PM; Callen DF; Maira SM; Hackl W; McArthur GA; Solomon B
Mol Cancer Res; 2011 Dec; 9(12):1696-707. PubMed ID: 22009179
[TBL] [Abstract][Full Text] [Related]
38. Rapid Diminution in the Level and Activity of DNA-Dependent Protein Kinase in Cancer Cells by a Reactive Nitro-Benzoxadiazole Compound.
Silva VA; Lafont F; Benhelli-Mokrani H; Breton ML; Hulin P; Chabot T; Paris F; Sakanyan V; Fleury F
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187356
[TBL] [Abstract][Full Text] [Related]
39. PKM2: A Potential Regulator of Rheumatoid Arthritis via Glycolytic and Non-Glycolytic Pathways.
Xu D; Liang J; Lin J; Yu C
Front Immunol; 2019; 10():2919. PubMed ID: 31921178
[TBL] [Abstract][Full Text] [Related]
40. Expression of the DNA-dependent protein kinase catalytic subunit is associated with the radiosensitivity of human thyroid cancer cell lines.
Ihara M; Ashizawa K; Shichijo K; Kudo T
J Radiat Res; 2019 Mar; 60(2):171-177. PubMed ID: 30476230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
